Exploring the Use of Saliva for the Detection of Group A Streptococcus
Trial Snapshot
- Phase
- Not Applicable
- Status
- Active, not recruiting
- Enrollment
- 200
- Locations
- 4
- Primary Endpoint
- Rate and sensitivity of GAS detection
Study Overview
Brief Summary
This study is being done to evaluate whether saliva can be used to diagnose GAS infection and also to compare different testing methods in the microbiology lab. The saliva sample testing will be compared to the throat swab testing to see if saliva testing works as well. The lab will also try different testing methods to see if a faster type of testing (e.g. molecular testing) works as well as the regular method, which takes 48 hours to get results.
This is important because throat swabs can be challenging to collect in some children, and saliva is often much easier and more acceptable by children to collect. This could improve our ability to accurately diagnose and treat GAS infections.
Study Design
- Study Type
- Interventional
- Allocation
- Na
- Intervention Model
- Single Group
- Primary Purpose
- Diagnostic
- Masking
- None
Eligibility Criteria
- Ages
- 0 Years to 18 Years (Child, Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •< 19 years of age
- •Have provided a sample for GAS testing (bacterial throat swab or POCT rapid antigen test) at the discretion of the clinical team
- •Able to provide a saliva sample
Exclusion Criteria
- •Parent/guardian and/or patient unable to consent or assent
- •Unable to provide a saliva sample
Arms & Interventions
Saliva collection
Self-collected saliva sample
Intervention: Saliva collection (Diagnostic Test)
Outcomes
Primary Outcomes
Rate and sensitivity of GAS detection
Time Frame: Within 24 hours of collection
compare the rate and sensitivity of GAS detection by throat bacterial culture, throat molecular detection and saliva molecular detection according to a semi-quantitative value (quantified growth on bacterial culture or CT value for molecular assays)
Secondary Outcomes
No secondary outcomes reported
Investigators
Aaron Campigotto
Division Head Microbiology
The Hospital for Sick Children
